Pfizer Lines up Arena Pharmaceuticals for a $6.7 Billion Cash Deal
(Pfizer) Pfizer Inc. is expecting to acquire drugmaker Arena Pharmaceuticals in a cash deal valued at $6.7 billion. The addition of Arena expands Pfizer’s product portfolio, with the target known…